Curriculum vitae
PERSONAL INFORMATION
Lieven Dupont
WORK EXPERIENCE January 2000–Present
Consultant Respiratory Medicine, Head of Clinic University Hospital Leuven (Belgium)
January 2000–Present
Associate Professor of Medicine Univeristy of Leuven (Belgium)
January 2002–Present
Senior Clinical Research Fellow FWO Vlaanderen (Belgium)
EDUCATION AND TRAINING October 1984–June 1991
Medical Degree University of Leuven (Belgium)
July 1991–July 1998
Internal Medicine Specialist Univeristy of Leuven (Belgium)
August 1998–December 1999
Respiratory Medicine Specialist Uiversity of Leuven (Belgium)
August 1995–December 1999
PhD (Doctor of Biomedical Sciences) Univeristy of Leuven (Belgium)
ADDITIONAL INFORMATION Expertise
• outpatient clinic University Hospitals Leuven on severe asthma, chronic cough, adult cystic fibrosis and bronchiectasis • Principal investigator for several clinical trials (RCT) in severe asthma and bronchiectasis at University Hospitals Leuven • member of the executive committee of the Forum Vlaamse Longartsen • member of the executive committee of the medical assembly of the Mucovereniging Belgium • head of the Protocol Review Committee and member of the executive committee of the CTN (Clinical Trial Network) within the ECFS (European cystic Fibrosis Society) • medical director of the Aconcagua project and the Climbing for Life project • medical advisor of the KBWB (Koninlijke Belgische WielrijdersBond)
Publications
Papers in journals included in the ISI Web of Science: 2015 Boon M, Verleden SE, Bosch B, Lammertyn EJ, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens HA, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Van Raemdonck DE, Decramer M, Verleden GM, Hogg JC, Dupont LJ, Vanaudenaerde BM, De Boeck K. Morphometric Analysis of Explant Lungs in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2015 Nov 9. [Epub ahead of print].
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 1 / 16
Curriculum vitae
Lieven Dupont
Impact Factor 12.996 Dewulf J, Vermeulen F, Wanyama S, Thomas M, Proesmans M, Dupont L, De Boeck K. Treatment burden in patients with at least one class IV or V CFTR mutation. Pediatric Pulmonology. 2015 Nov 5. doi: 10.1002/ppul.23313. [Epub ahead of print]. Impact Factor 2.704 Frans G, Moens L, Schrijvers R, Wuyts G, Bouckaert B, Schaballie H, Dupont L, Bossuyt X, Corveleyn A, Meyts I. PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome. Journal of Clinical Immunology. 2015 Oct 15. [Epub ahead of print]. Impact Factor 3.184 Yserbyt J, Dooms C, Vos R, Dupont LJ, Van Raemdonck DE, Verleden GM. Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience. European Journal of Cardiothoracic Surgery. 2015 Oct 13. pii: ezv363. [Epub ahead of print]. Impact Factor 3.304 Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM, Somers J, Schoonis A, Schaevers V, Van Raemdonck DE, Neyrinck A, Dupont LJ, Yserbyt J, Verleden GM, Vos R. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial. American Journal of Transplantation. 2015 Aug 4. doi: 10.1111/ajt.13417. [Epub ahead of print]. Impact Factor 5.683. Testelmans D, Belge C, Vos R, Yserbyt J, Ciarka A, Dupont L, Verleden GM, Buyse B. Sleep Disordered Breathing After Lung Transplantation: A Prospective Study. Transplantation. 2015 Sep;99(9):e157-8. Impact Factor 3.828. Desie N, Van Raemdonck DE, Ceulemans LJ, Nevens F, Verslype C, Vansteenbergen W, Pirenne J, Monbaliu D, Roskams T, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Verleden GM, Vos R. Combined or Serial Liver and Lung Transplantation for Epithelioid Hemangioendothelioma: A Case Series. American Journal of Transplantation. 2015 Aug 19. doi: 10.1111/ajt.13430. [Epub ahead of print]. Impact Factor 5.683. Vandermeulen E, Verleden SE, Ruttens D, Moelants E, Mortier A, Somers J, Bellon H, Piloni D, Dupont LJ, Van Raemdonck DE, Proost P, Schols D, Vos R, Verleden GM, Vanaudenaerde BM. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance. Transplant Immunology. 2015 Sep;33(1):37-44. Impact Factor 1.457. Goeminne PC, Nawrot TS, De Boeck K, Nemery B, Dupont LJ. Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A casecontrol analysis. Journal of Cystic Fibrosis 2015 Nov;14(6):741-7. Impact Factor 3.190. Yserbyt J, Dupont L, Ninane V, Dooms C. To boldly go where no bronchoscope has gone before. American Journal of Respiratory and Critical Care Medicine. 2015 Apr 15;191(8):956. Impact Factor 12.996 Verleden GM, Vos R, Vanaudenaerde B, Dupont L, Yserbyt J, Van Raemdonck D, Verleden S. Current views on chronic rejection after lung transplantation. Transplant Immunology. 2015 Oct;28(10):1131-9. Impact Factor 1.457 Seys SF, Feyen L, Keirsbilck S, Adams E, Dupont LJ, Nemery B. An outbreak of swimming-pool related respiratory symptoms: An elusive source of trichloramine in a municipal indoor swimming pool. International Journal of Hygiene and Environmental Health. 2015 Jun;218(4):386-91. Impact Factor 2.493. Ruttens D, Vandermeulen E, Verleden SE, Bellon H, Vos R, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden GM.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 2 / 16
Curriculum vitae
Lieven Dupont
Role of genetics in lung transplant complications. Annals of Medicine. 2015 Mar;47(2):106-15. Janssens T, Brepoels S, Dupont L, Van den Bergh O. The impact of harmfulness information on citric acid induced cough and urge-to-cough. Pulmonary Pharmacology Therapeutics. 2015 Apr;31:9-14. Impact Factor 2.937 Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden G, Vos R. Restrictive chronic lung allograft dysfunction: Where are we now? Journal of Heart & Lung Transplantation. 2015 May;34(5):625-30. Impact Factor 6.650 Seys SF, Hox V, Van Gerven L, Dilissen E, Marijsse G, Peeters E, Dekimpe E, Kasran A, Aertgeerts S, Troosters T, Vanbelle V, Peers K, Ceuppens JL, Hellings PW, Dupont LJ, Bullens DM. Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers. Allergy. 2015 Feb;70(2):187-94. Impact Factor 5.995. Bullens DM, Seys S, Kasran A, Dilissen E, Dupont LJ, Ceuppens JL. Low cord blood Foxp3/CD3γ mRNA ratios: a marker of increased risk for allergy development. Clinical & Experimental Allergy. 2015 Jan;45(1):232-7. Impact Factor 4.324. 2014 Vos R, Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Neyrinck A, Van Raemdonck DE, Yserbyt J, Dupont LJ, Verbeken EK, Moelants E, Mortier A, Proost P, Schols D, Cox B, Verleden GM, Vanaudenaerde BM. Azithromycin and the Treatment of Lymphocytic Airway Inflammation After Lung Transplantation. American Journal of Transplantation. 2014 Nov 13. [Epub ahead of print]. Impact Factor 2.752. Verleden GM, Vos R, Dupont L, Van Raemdonck DE, Vanaudenaerde BM, Verleden SE. Are we near to an effective drug treatment for bronchiolitis obliterans? Expert Opinion on Pharmacotherapy. 2014;15(15):2117-20. Impact Factor 3.085. Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJ, O'Dochartaigh C, van Haren EH, Vidal LO, Welte T, Fox HG, Wu J, Charlton B. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax. 2014;69(12):1073-9. Impact Factor 8.562. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT. The bronchiectasis severity index. An international derivation and validation study. American Journal of Respiratory and Critical Care Medicine. 2014;189(5):576-85. Impact Factor 11.986. Times Cited: 5 (from Web of Science). Goeminne PC, Bijnens E, Nemery B, Nawrot TS, Dupont LJ. Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis. Respiratory Research. 2014;15:108. Impact Factor 3.382. Peetermans M, Goeminne P, De Boeck C, Dupont LJ. IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease. Chest. 2014;146(3):e99-e100. Impact Factor 7.132. Marijsse GS, Seys SF, Schelpe AS, Dilissen E, Goeminne P, Dupont LJ, Ceuppens JL, Bullens DM. Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern. American Journal of Respiratory and Critical Care Medicine. 2014;189(10):1284-5. Impact Factor 11.986. Janssens T, Silva M, Davenport PW, Van Diest I, Dupont LJ, Van den Bergh O. Attentional modulation of reflex cough.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 3 / 16
Curriculum vitae
Lieven Dupont
Chest. 2014;146(1):135-41. Impact Factor 7.132. Boon M, Smits A, Cuppens H, Jaspers M, Proesmans M, Dupont LJ, Vermeulen FL, Van Daele S, Malfroot A, Godding V, Jorissen M, De Boeck K. Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure. Orphanet Journal of Rare Diseases. 2014;9:11. Impact Factor 3.960. Times Cited: 1 (from Web of Science). Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respiratory Medicine. 2014;108(2):287-96. Impact Factor 2.917. Ninane V, Brusselle GG, Louis R, Dupont L, Liistro G, De Backer W, Schlesser M, Vincken W. Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Expert Opinion on Drug Delivery. 2014;11(3):313-23. Impact Factor 4.116. Times Cited: 1 (from Web of Science). Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ. The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology. 2014;19(2):203-10. Impact Factor 3.495. Times Cited: 1 (from Web of Science). Vermeulen E, Maertens J, Meersseman P, Saegeman V, Dupont L, Lagrou K. Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital. Clinical Microbiology and Infection. 2014;20(5):O333-5. Impact Factor: 4.578 Fayon M, Kent L, Bui S, Dupont L, Sermet I; On behalf of the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee. Clinimetric properties of broncho-alveolar lavage inflammatory markers in cystic fibrosis. European Respiratory Journal, 2014;43(2):610-26. Impact Factor 7.125 2013 Verleden SE, Vandermeulen E, Ruttens D, Vos R, Vaneylen A, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Seminars in Respiratory and Critical Care Medicine. 2013;34(3):352-60. Impact Factor 2.752. Times Cited: 4 (from Web of Science). Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation. 2013;95(9):1167-72. Impact Factor 3.781. Times Cited: 7 (from Web of Science). Dierickx D, Tousseyn T, Requile' A, Verscuren R, Sagaert X, Morscio J, Wlodarska I, Herreman A, Kuypers D, Van Cleemput J, Nevens F, Dupont L, Uyttebroeck A, Pirenne J, De Wolf-Peeters C, Verhoef G, Brepoels L, Gheysens O. The accuracy of PET in the detection of Posttransplant Lymphoproliferative Disorder (PTLD). Haematologica 2013;98(5):771-5. Impact Factor 5.935. Times Cited: 2 (from Web of Science). Witters P, Dupont L, Vermeulen F, Proesmans M, Cassiman D, Wallemacq P, De Boeck K. Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles. Journal of Cystic Fibrosis 2013 May;12(3):222-8. Impact Factor 3.190. Times Cited: 1 (from Web of Science). Pauwels A, Verleden S, Farre R, Vanaudenaerde BM, Van Raemdonck D, Verleden G, Sifrim D, Dupont LJ. The effect of gastric juice on interleukin-8 production by cystic fibrosis primary bronchial epithelial cells. Journal of Cystic Fibrosis 2013 [Epub ahead of print]. Impact Factor 3.190. Vos R, Verleden SE, Ruttens D, Vandermeulen E, Yserbyt J, Dupont LJ, Van Raemdonck DE, De Raedt N, Gheysens O, De Jong PA, Verleden GM, Vanaudenaerde BM.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 4 / 16
Curriculum vitae
Lieven Dupont
Pirfenidone: A Potential New Therapy for Restrictive Allograft Syndrome? American Journal of Transplantation. 2013. [Epub ahead of print]. Impact Factor 6.394. Times Cited: 1 (from Web of Science). Bullens DM, Decraene A, Seys S, Dupont LJ. IL-17A in human respiratory diseases: innate or adaptive immunity? Clinical implications. Clinical and Developmental Immunology 2013; [Epub ahead of print]. Impact Factor 3.064. Seys SF, Daenen M, Dilissen E, Van Thienen R, Bullens DM, Hespel P, Dupont LJ. Effects of high altitude and cold air exposure on airway inflammation in patients with asthma. Thorax 2013;68(10):906-13. Impact Factor 6.840. Times Cited: 4 (from Web of Science). Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, Young KR, Saiman L, Burns JL, Govan JR, Ramsey B, Gupta R; Arikace Study Group. Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection. Thorax 2013;68(9):818-25. Impact Factor 6.840. Times Cited: 16 (from Web of Science). Grabowski M, Seys S, Decraene A, Kasran A, Dilissen E, Barg W, Medrala W, Dupont LJ, Panaszek B, Bullens DM. Airway inflammation in patients with chronic non-asthmatic cough. Thorax. 2013;68(2):125-30. Impact Factor 6.840. Times Cited: 1 (from Web of Science). Goeminne P, Kiciński M, Vermeulen F, Fierens F, De Boeck K, Nemery B, Nawrot TS, Dupont LJ. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143(4):946-54. Impact Factor 5.250. Times Cited: 3 (from Web of Science). Seys SF, Grabowski M, Adriaensen W, Decraene A, Dilissen E, Vanoirbeek JA, Dupont LJ, Ceuppens JL, Bullens DM. Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma. Clinical & Experimental Allergy. 2013;43(9):1009-17. Impact Factor: 4.789. Times Cited: 5 (from Web of Science). Havermans T, Colpaert K, De Boeck K, Dupont L, Abbott J. Pain in CF: review of the literature. Journal of Cystic Fibrosis 2013;12(5):423-30. Impact Factor 3.190. Times Cited: 1 (from Web of Science). Burtin C, Van Remoortel H, Vrijsen B, Langer D, Colpaert K, Gosselink R, Decramer M, Dupont L, Troosters T. Impact of exacerbations of cystic fibrosis on muscle strength. Respiratory Research.2013;14:46. Impact Factor 3.360. Times Cited: 1 (from Web of Science). Verleden SE, Vos R, Vandermeulen E, Ruttens D, Vaneylen A, Dupont LJ, Verbeken EK, Verleden GM, Van Raemdonck DE, Vanaudenaerde BM. Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patients. Journal of Heart and Lung Transplantation. 2013;32(4):447-53. Impact Factor 4.332. Callebaut I, Hox V, Bobic S, Bullens DM, Janssens W, Dupont L, Hellings PW. Effect of nasal anti-inflammatory treatment in chronic obstructive pulmonary disease. American Journal of Rhinology & Allergy. 2013;27(4):273-7. Impact Factor 1.744. 2012 Pauwels A, Blondeau K, Dupont LJ, Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. American Journal of Gastroenterology. 2012;107(9):1346-53. Impact Factor 7.282. Times Cited: 7 (from Web of Science). Verleden SE, Scheers H, Nawrot TS, Vos R, Fierens F, Geenens R, Yserbyt J, Wauters S, Verbeken EK, Nemery B, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM. Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution. American Journal of Transplantation. 2012;12(7):1831-8. Impact Factor 6.394. Times Cited: 6 (from
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 5 / 16
Curriculum vitae
Lieven Dupont
Web of Science). Vos R, Vanaudenaerde BM, Verleden SE, Ruttens D, Vaneylen A, Van Raemdonck DE, Dupont LJ, Verleden GM. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation. 2012;94(2):101-9. Impact Factor 4.003. Times Cited: 11 (from Web of Science). Yserbyt J, Verleden GM, Dupont LJ, Van Raemdonck DE, Dooms C. Bronchial carcinoma after lung transplantation: a single-center experience. Journal of Heart and Lung Transplantation. 2012;31(6):585-90. Impact Factor 4.332. Times Cited: 4 (from Web of Science). Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective crosssectional analysis of CT diagnosed bronchiectatic patients. Respiratory Research. 2012;13:21. Impact Factor 3.360. Times Cited: 9 (from Web of Science). Pauwels A, Decraene A, Blondeau K, Mertens V, Farre R, Proesmans M, Van Bleyenbergh P, Sifrim D, Dupont LJ. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest. 2012;141(6):1568-74. Impact Factor 5.250. Times Cited: 13 (from Web of Science). Verleden SE, Vos R, Geenens R, Ruttens D, Vaneylen A, Dupont LJ, Verleden GM, van Raemdonck DE, Vanaudenaerde BM. Vitamin D deficiency in lung transplant patients: is it important? Transplantation. 2012;93(2):224-9. Impact Factor 4.003. Times Cited: 5 (from Web of Science). Goeminne PC, Verschueren P, Scheers H, Dupont LJ. Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis. Clinical Rheumatology. 2012;31(2):367-73. Impact Factor 1.996. Van den Bergh O, Van Diest I, Dupont L, Davenport PW. On the psychology of cough. Lung 2012;190(1):55-61. Impact Factor 2.062. Times Cited: 7 (from Web of Science). Goeminne PC, Vandendriessche T, Van Eldere J, Nicolai BM, Hertog ML, Dupont LJ. Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis. Respiratory Research. 2012;13:87. Impact Factor 3.360. Times Cited: 3 (from Web of Science). Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ. A cohort description and analysis of the effect of gabapentin on idiopathic cough. Cough. 2012;8(1):9. Impact Factor 1.210 2011 Witters P, Libbrecht L, Roskams T, Boeck KD, Dupont L, Proesmans M, Vermeulen F, Strandvik B, Lindblad A, Sté phenne X, Sokal E, Gosseye S, Heye S, Maleux G, Aerts R, Monbaliu D, Pirenne J, Hoffman I, Nevens F, Cassiman D. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology. 2011;53(3):1064-5. Impact Factor 11.665. Times Cited: 6 (from Web of Science). Verleden GM, Vos R, Verleden SE, De Wever W, De Vleeschauwer SI, Willems-Widyastuti A, Scheers H, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM. Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation. 2011;92(6):703-8. Impact Factor 4.003. Times Cited: 25 (from Web of Science). Pauwels A, Blondeau K, Mertens V, Farre R, Verbeke K, Dupont LJ, Sifrim D. Gastric emptying and different types of reflux in adult patients with cystic fibrosis. Alimentary Pharmacology & Therapeutics. 2011;34(7):799-807. Impact Factor 3.769. Times Cited: 11
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 6 / 16
Curriculum vitae
Lieven Dupont
(from Web of Science). Verleden SE, Vandooren J, Vos R, Willems S, Dupont LJ, Verleden GM, Van Raemdonck DE, Opdenakker G, Vanaudenaerde BM. Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients. Transplantation Immunology. 2011;25(2-3):159-62. Impact Factor 1.459. Times Cited: 9 (from Web of Science). Sands D, Repetto T, Dupont LJ, Korzeniewska-Eksterowicz A, Catastini P, Madge S. End of life care for patients with cystic fibrosis. Journal of Cystic Fibrosis. 2011;10 Suppl 2:S37-44. Impact Factor 3.190. Times Cited: 9 (from Web of Science). Stanzi A, Tiek J, Wauters S, Decaluwe H, Coosemans W, De Leyn P, Nafteux P, Dupont LJ, Verleden GM, Van Raemdonck DE. Cadaveric lobar lung transplant: a valiod option for small sized CF patients. Transplant International. 2011;24(S2):76-77. Impact Factor 2.921. Vleeschauwer SI, Wauters S, Dupont LJ, Verleden SE, Willems-Widyastuti A, Vanaudenaerde BM, Verleden GM, Van Raemdonck DE. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. Journal of Heart and Lung Transplantation. 2011;30(9):975-81. Impact Factor 4.332. Times Cited: 14 (from Web of Science). Vos R, Vanaudenaerde BM, Verleden SE, Van Raemdonck DE, Dupont LJ, Verleden GM. Azithromycin in posttransplant bronchiolitis obliterans syndrome. Chest. 2011;139(5):1246; author reply 1247. Impact Factor 5.250. Nawrot TS, Vos R, Jacobs L, Verleden SE, Wauters S, Mertens V, Dooms C, Hoet PH, Van Raemdonck DE, Faes C, Dupont LJ, Nemery B, Verleden GM, Vanaudenaerde BM. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax. 2011;66(9):748-54. Impact Factor 6.840. Times Cited: 6 (from Web of Science). Times Cited: 26 (from Web of Science). Verleden GM, Verleden SE, Vos R, De Vleeschauwer SI, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Transplant International. 2011;24(7):651-6. Impact Factor 2.921. Times Cited: 5 (from Web of Science). Verleden SE, Vos R, Mertens V, Willems-Widyastuti A, De Vleeschauwer SI, Dupont LJ, Verleden GM, Van Raemdonck DE, Vanaudenaerde BM. Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavage. J Heart Lung Transplant. 2011;30(6):667-73. Impact Factor 4.332. Times Cited: 13 (from Web of Science). V. Mertens, K. Blondeau, B. Vanaudenaerde, R. Vos, A. Pauwels, G. Verleden, D.E. Van Raemdonck, D. Sifrim, L.J. Dupont. Bile Acids Aspiration Reduces Survival in Lung Transplant Recipients with BOS Despite Azithromycin. American Journal of Transplantation, 2011;11(2):329-35. Impact Factor 6.394. Times Cited: 17 (from Web of Science). Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, Dupont LJ, Verleden GM. Diagnostic value of antibodies against Pseudomonas aeruginosa in bronchoalveolar lavage fluid after lung transplantation. Transplantation Proceedings. 2010;42(10):4415-20. Impact Factor 0.993. Times Cited: 3 (from Web of Science). Vanaudenaerde BM, Verleden SE, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Geenens R, Van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 7 / 16
Curriculum vitae
Lieven Dupont
Innate and adaptive IL-17 producing lymphocytes in chronic inflammatory lung disorders (Review) American Journal of Respiratory and Critical Care Medicine 2011;183(8):977-86. Impact Factor 11.080. Times Cited: 25 (from Web of Science). Holgate S.T., Noonan M., Chanez P., Busse W., Dupont L., Pavord I., Hakulinen A., Paolozzi L., Wajdula J., Zang C., Nelson H., Raible D. A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Etanercept in Subjects with Moderate to Severe Persistent Asthma. European Respiratory Journal, 2011;37(6):1352-9. Impact Factor 5.895. Times Cited: 36 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S.E. Verleden, S.I. De Vleeschauwer, A. Willems-Widyastuti, D.E. Van Raemdonck, A. Schoonis, T.S. Nawrot, L.J. Dupont, G.M. Verleden. A randomized placebo-controlled trial of azithromycin to prevent bronchiolitis obliterans syndrome after lung transplantation. European Respiratory Journal 2011;37(1):164-72. Impact Factor 5.895. Times Cited: 53 (from Web of Science). K. Blondeau, V. Mertens, L.J. Dupont, A. Pauwels, R. Farré, A. Malfroot, E. De Wachter, I. De Schutter, B. Hauser, Y. Vandenplas, D. Sifrim. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings. Pediatric Pulmonology. 2011;46(3):286-294. Impact Factor 2.533. Times Cited: 2 (from Web of Science). Van den Bergh O, Van Diest I, Dupont L, Davenport PW. On the psychology of cough. Lung. 2012;190(1):55-61. Impact Factor 1.899. De Vleeschauwer S, Vanaudenaerde B, Vos R, Meers C, Wauters S, Dupont L, Van Raemdonck D, Verleden G. The need for a new animal model for chronic rejection after lung transplantation. Transplantation Proceedings. 2011;43(9):3476-85. Impact Factor 1.005. Verleden GM, Vos R, De Vleeschauwer S, Verleden S, Dupont L, Nevens F, Verbeken E, Vanaudenaerde BM. Neutrophilic reversible airways dysfunction after liver transplantation: a case report. Transplantation Proceedings. 2011;43(5):2078-81. Impact Factor 1.005. Grabowski M, Kasran A, Seys S, Pauwels A, Medrala W, Dupont L, Panaszek B, Bullens D. Pepsin and bile acids in induced sputum of chronic cough patients. Respiratory Medicine. 2011;105(8):1257-61. Impact Factor 2.475. Times Cited: 8 (from Web of Science). 2010 B.M. Vanaudenaerde, S.E. Verleden, S.I. De Vleeschauwer, A. Willems-Widyastuti, D.E. Van Raemdonck, L.J. Dupont, T.S. Nawrot, E.K. Verbeken, G.M. Verleden. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. European Respiratory Journal. 2010;29(11):1259-69. Impact Factor 5.922. Times Cited: 12 (from Web of Science). R. Vos, B.M. Vanaudenaerde, A. Ottevaere, S.E. Verleden, S.I. De Vleeschauwer, A. WillemsWidyastuti, S. Wauters, D.E. Van Raemdonck, T.S. Nawrot, L.J. Dupont, G.M. Verleden. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer? Journal of Heart and Lung Transplantation. 2010;29(12):1358-68. Impact Factor 3.426. Times Cited: 38 (from Web of Science). R. Vos, K. De Vusser, V. Schaevers, A. Schoonis, V. Lemaigre, F. Dobbels, K. Desmet, B.M. Vanaudenaerde, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. Smoking resumption after lung transplantation: a sobering truth. European Respiratory Journal. 2010;35(6):1411-3. Impact Factor 5.922. Times Cited: 6 (from Web of Science).
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 8 / 16
Curriculum vitae
Lieven Dupont
V. Mertens, K. Blondeau, B. Vanaudenaerde, R. Vos, R. Farre, A. Pauwels, G. Verleden, D. Van Raemdonck, L. Dupont, D. Sifrim. Gastric juice from patients "on" acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells. Journal of Clinical Gastroenterology. 2010;44(10):e230-5. Impact Factor 2.752. Times Cited: 10 (from Web of Science). W. Janssens, H. Nuytten, L.J. Dupont, J. Van Eldere, S. Vermeire, D. Lambrechts, K. Nackaerts, M. Decramer, J.J. Cassiman, H. Cuppens. Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2010;182(2):163-9. Impact Factor 10.191. Times Cited: 19 (from Web of Science). A. Decraene, A. Willems-Widyastuti, K. De Boeck, D.M. Bullens, L.J. Dupont. Elevated expression of IL-17A and IL-23 in CF patients infected with Pseudomonas aeruginosa. Respiratory Research, 2010;11:177. Impact Factor 2.859. Times Cited: 26 (from Web of Science). P. Goeminne, L.J. Dupont. The sinusitis-infertility syndrome: Young's saint, old devil. European Respiratory Journal. 2010;35(3):698. Impact Factor 5.922. Times Cited: 3 (from Web of Science). K. Blondeau, A. Pauwels, L.J. Dupont, V. Mertens, M. Proesmans, R. Orel, J. Brecelj, M. LópezAlonso, M. Moya, A. Malfroot, E. De Wachter, Y. Vandenplas, B. Hauser, D. Sifrim. Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 2010;50(2):161-6. Impact Factor 2.180. Times Cited: 21 (from Web of Science). P. Goeminne, L. Dupont. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgraduate Medical Journal. 2010;86(1018):493-501. Impact Factor 1.518. Times Cited: 24 (from Web of Science). 2009 O.O. Okusanya, S.M. Bhavnani, J. Hammel, P. Minic, L.J. Dupont, A. Forrest, G.J. Mulder, C. Mackinson, P.G. Ambrose, R. Gupta. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrobial Agents Chemotherapy, 2009;53(9):3847-54. Impact Factor 4.390. Times Cited: 30 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S. De Vleeschauwer, A. Willems-Widyastuti, L.J. Dupont, D.E. Van Raemdonck, G.M. Verleden. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation. Transplantation Proceedings, 2009;41(8):3409-13. Impact Factor 1.055. Times Cited: 2 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S.I. De Vleeschauwer, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome? Transplantation Proceedings, 2009;41(2):595-8. Impact Factor 1.055. Times Cited: 8 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S.I. De Vleeschauwer, D.E. Van Raemdonck, L.J. Dupont, E.K. Verbeken, W. De Wever W, G.M. Verleden. Follicular bronchiolitis: a rare cause of bronchiolitis obliterans syndrome after lung transplantation: a case report. American Journal of Transplantation, 2009;9(3):644-50. Impact Factor 6.423. Times Cited: 7 (from
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 9 / 16
Curriculum vitae
Lieven Dupont
Web of Science). G.M. Verleden, L.J. Dupont, D.E. Van Raemdonck. ABPA: does it really exist after lung transplantation? Journal of Heart and Lung Transplantation 2009;28(11):1239. Impact Factor 3.087. Times Cited: 0 (from Web of Science). T. Troosters, D. Langer, B. Vrijsen, J. Segers, K. Wouters, W. Janssens, R. Gosselink, M. Decramer, L. Dupont. Skeletal muscle weakness, exercise tolerance and Physical activity in adults with Cystic Fibrosis. European Respiratory Journal, 2009;33(1):99-106. Impact Factor 5.349. Times Cited: 47 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S. De Vleeschauwer, A. Willems-Widyastuti, H. Scheers, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome. Journal of Heart and Lung Transplantation 2009;28(8):799-807. Impact Factor 3.087. Times Cited: 12 (from Web of Science). G. Brusselle, A. Michils, R. Louis, L. Dupont, B. Van de Maele, A. Delobbe, C. Pilette, C.S.Lee, S. Gurdain, S. Vancayzeele, P. Lecomte, C. Hermans, K. MacDonald, M. Song, I. Abraham. “Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study. Respiratory Medicine, 2009;103(11):1633-42. Impact Factor 2.223. Times Cited: 40 (from Web of Science). G.M. Verleden, Y. Lievens, L.J. Dupont, D.E. Van Raemdonck, S.I. De Vleeschauwer, R. Vos, B. Vanaudenaerde. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. Transplantation Proceedings, 2009;41(5):1816-20. Impact Factor 1.055. Times Cited: 9 (from Web of Science). G.M. Verleden. R. Vos, S.I. De Vleeschauwer, A. Willems-Widyastuti, S.E. Verleden, L.J. Dupont, D.E. Van Raemdonck, B.M. Vanaudenaerde Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transplant International, 2009;22(8):771-9. Impact Factor 2.300. Times Cited: 35 (from Web of Science). D. Langer, R. Gosselink, F. Pitta, C. Burtin, G. Verleden, L. Dupont, M. Decramer, T. Troosters. Physical activity in daily life 1 year after lung transplantation. Journal of Heart and Lung Transplantation 2009;28(6):572-8. Impact Factor 3.087. Times Cited: 15 (from Web of Science). A.K. Azad, R. Rauh, F; Vermeulen, M. Jaspers, J. Korbmacher, B. Boissier,.Y. Fichou, M. des Georges, F. Stanke, H. Nuytten, K. De Boeck, L. Dupont, M. Balaščáková, L. Hjelte, P. Lebecque, D. Radojkovic, C. Castellani, M. Schwartz, M. Stuhrmann, M. Schwarz, S. Hagens, L. Fila, I. de Monestrol, E. Girodon, C. Férec, M. Claustres, B. Tümmler, J Cassiman, C. Korbmacher, H. Cuppens. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Human Mutation, 2009;30(7):1093-103. Impact Factor 7.033. Times Cited: 32 (from Web of Science). R. Vos, C. Cordemans, B.M. Vanaudenaerde, S.I. De Vleeschauwer, A. Schoonis, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation. Transplantation, 2009;87(10):1579-83. Impact Factor 3.641. Times Cited: 13 (from Web of Science). F. Dobbels, J. Vanhaecke, L. Dupont, F. Nevens, G. Verleden, J. Pirenne, S. De Geest. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation, 2009;87(10):1497-504. Impact Factor 3.641. Times Cited: 60 (from Web of Science). S.I. De Vleeschauwer, D.E. Van Raemdonck, B.M. Vanaudenaerde, R. Vos, C.M. Meers, S. Wauters,
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 10 / 16
Curriculum vitae
Lieven Dupont
W. Coosemans, H. Decaluwe, P. De Leyn, P. Nafteux, L.J. Dupont, T.E. Lerut, G.M. Verleden. Early outcome after lung transplantation from non-heart-beating donors is comparable to heartbeating donors. Journal of Heart and Lung Transplantation, 2009;28(4):380-7. Impact Factor 3.087. Times Cited: 35 (from Web of Science). T. Havermans, K. Colpaert, L. Vanharen, L.J. Dupont. Health related quality of life in cystic fibrosis: To work or not to work? Journal of Cystic Fibrosis, 2009;8(3):218-23. Impact Factor 1.550. Times Cited: 14 (from Web of Science). V. Mertens, K. Blondeau, A. Pauwels, R. Farre, B.M. Vanaudenaerde, R. Vos, G.M. Verleden, D.E. Van Raemdonck, L.J. Dupont, D. Sifrim. Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Digestive Diseases and Sciences, 2009;54(5):972-9. Impact Factor 1.583. Times Cited: 34 (from Web of Science). K. Blondeau, V. Mertens, B.M. Vanaudenaerde, G.M. Verleden, D.E. Van Raemdonck, D. Sifrim, L.J. Dupont. Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. Journal of Heart and Lung Transplantation, 2009;28(2):141-8. Impact Factor 3.087. Times Cited: 19 (from Web of Science). A. Pauwels, K. Blondeau, L. Dupont, D. Sifrim. Cough and gastroesophageal reflux: from the gastroenterologist end. Pulmonary Pharmacology Therapeutics, 2009;22(2):135-8. Impact Factor 2.283. Times Cited: 11 (from Web of Science). P. Witters, K. De Boeck, L. Dupont , M. Proesmans , F. Vermeulen , R. Servaes , C. Verslype, W. Laleman , F. Nevens , I. Hoffman, D. Cassiman . Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis. 2009;8(6):392-9. Times Cited: 24 (from Web of Science). 2008 A. Billen, L. Dupont. B. Exercise induced bronchoconstriction and sports. Postgraduate Medical Journal, 2008;84(996):512-7. Impact Factor 1.587. Times Cited: 5 (from Web of Science). T. Havermans, K. Colpaert, L.J. Dupont. Quality of life in patients with Cystic Fibrosis: Association with anxiety and depression. Journal of Cystic Fibrosis, 2009;7(6):581-4. Impact Factor 1.550. Times Cited: 22 (from Web of Science). K. Blondeau, V. Mertens, D.E. Van Raemdonck, G.M. Verleden, D. Sifrim, L.J. Dupont. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with and without chronic allograft rejection. European Respiratory Journal, 2008;31(4):707-13. Impact Factor 5.349. Times Cited: 81 (from Web of Science). R. Vos, B.M. Vanaudenaerde, N Geudens, L.J. Dupont, D.E. Van Raemdonck, G.M. Verleden. Pseudomonal airway colonization is associated with an increased prevalence of Bronchiolitis Obliterans Syndrome after lung transplantation. European Respiratory Journal, 2008; 31(5):1037-45. Impact Factor 5.349. Times Cited: 52 (from Web of Science). R. Vos, K. Blondeau, B.M. Vanaudenaerde, V. Mertens, N. Geudens, D.E. Van Raemdonck, D. Sifrim, L.J. Dupont, G.M. Verleden Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? Journal of Heart and Lung Transplantation, 2008; 27(8):843-9. Impact Factor 3.087. Times Cited: 31 (from Web of Science).
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 11 / 16
Curriculum vitae
Lieven Dupont
B.M. Vanaudenaerde, W.A. Wuyts, N. Geudens, T.S. Nawrot, R. Vos, L.J. Dupont, D.E. Van Raemdonck, G.M. Verleden. Broncho-alveolar lavage fluid recovery correlates with airway neutrophilia in lung transplant patients. Respiratory Medicine, 2008; 102(3):339-47. Impact Factor 2.223 . Times Cited: 7 (from Web of Science). B.M. Vanaudenaerde, I. Meyts, R. Vos, N. Geudens, E.K. Verbeken, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. A dichotomic development of Bronchiolitis Obliterans Syndrome after Lung Transplantation revealed by azithromycin. European Respiratory Journal, 2008; 32(4):832-843. Impact Factor 5.349. Times Cited: 87 (from Web of Science). B.M. Vanaudenaerde, S.I. De Vleeschauwer, R. Vos, I. Meyts, D.M. Bullens, V. Reynders, W.A. Wuyts, L.J. Dupont, D.E. Van Raemdonck, G.M. Verleden. The role of the IL23/IL17 axis in Bronchiolitis Obliterans Syndrome after Lung Transplantation. American Journal of Transplantation, 2008; 8(9): 1911-20. Impact Factor 6.423. Times Cited: 77 (from Web of Science). G. Hens, B. Vanaudenaerde, D.M.A. Bullens, M. Piessens, M. Decramer, L.J. Dupont, J.L. Ceuppens, P.W. Hellings. Sinonasal pathology in non-allergic asthma and COPD: “united airways” beyond the scope of allergy Allergy, 2008; 63(3): 261-267. Impact Factor 5.014. Times Cited: 52 (from Web of Science). G. Maury, D. Langer, G. Verleden, L. Dupont, R. Gosselink, M. Decramer, T. Troosters. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. American Journal of Transplantation, 2008; 8(6):1275-81. Impact Factor 6.423. Times Cited: 25 (from Web of Science). F. Dobbels, P. Moons, I. Abraham, C.P. Larsen, L. Dupont, S. De Geest. Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale. Transplant International, 2008; 21(8):764-73. Impact Factor 2.300. Times Cited: 11 (from Web of Science). K. Blondeau, L.J. Dupont, V. Mertens, G. Verleden, A. Malfroot, Y. Vandenplas, B. Hauser, D. Sifrim. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut. 2008; 57(8):1049-55. Impact Factor 10.015. Times Cited: 45 (from Web of Science). D.M. Bullens, A. Decraene, E. Dilissen, I. Meyts, K. De Boeck, L.J. Dupont, J.L. Ceuppens. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clinical Experimental Allergy. 2008; 38(9):1459-67. Impact Factor 3.729. Times Cited: 27 (from Web of Science). W.A. Wuyts, M. Thomeer, L.J. Dupont, G.M. Verleden. An algorithm for referral of patients with IPF for lung transplantation. Thorax, 2008; 63(3):292. Impact Factor 6.226. Times Cited: 1 (from Web of Science). R. Vos, B.M. Vanaudenaerde, S.I. De Vleeschauwer, D.E. Van Raemdonck, L.J. Dupont, G.M. Verleden. De novo or persistent pseudomonal airway colonization after lung transplantation: importance for bronchiolitis obliterans syndrome? Transplantation, 2008; 86(4):624-5. Impact Factor 3.641. Times Cited: 3 (from Web of Science). W.A. Wuyts, M. Thomeer, L.J. Dupont, G.M. Verleden. An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 2008; 177(12):1397. Impact Factor 9.074. Times Cited: 4 (from Web of Science). 2007 G.M. Verleden, L.J. Dupont, D.E. Van Raemdonck, R. Vos, B.M. Vanaudenaerde; Leuven Lung Transplant Group.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 12 / 16
Curriculum vitae
Lieven Dupont
Lung Transplantation: A 15-year Single-Center Experience. Clinical Transplantation, 2007:121-30. Impact Factor 1.923. Times Cited: 0 (from Web of Science). K. Blondeau, V. Mertens, L.J. Dupont, D. Sifrim. Improved diagnosis of gastroesophageal reflux in patients with unexplained chronic cough. Alimentary Pharmacology & Therapeutics, 2007; 2007: 25(6):723-32. Impact Factor 3.201. Times Cited: 70 (from Web of Science). F. Dobbels, J. Vanhaecke, F. Nevens, L. Dupont, G. Verleden, D. Van Hees, S. De Geest. Liver versus cardiothoracic transplant candidates and their pretransplant psychosocial and behavioral risk profiles: good neighbors or complete strangers? Transplant International, 2007; 20(12):1020-30. Impact Factor 2.300. Times Cited: 3 (from Web of Science). C. Van De Wauwer, D. Van Raemdonck, G.M. Verleden, L. Dupont, P. De Leyn, W. Coosemans, P. Nafteux, T. Lerut. Risk factors for airway complications within the first year after lung transplantation. European Journal of Cardiothoracic Surgery, 2007; 31:703-10. Impact Factor 2.011. Times Cited: 2 (from Web of Science). G.M. Verleden, R. Vos, B.M. Vanaudenaerde, D. Van Raemdonck, L.J. Dupont. Interleukin-17 and neutrophils are increased in BAL fluid during acute lung rejection. Chest, 2007; 131:1988-9. Impact Factor 4.143. Times Cited: 2 (from Web of Science). R. Vos, B.M. Vanaudenaerde, L.J. Dupont, D.E. Van Raemdonck, G.M. Verleden. Transient airway colonization is associated with airway inflammation after lung transplantation. American Journal of Transplantation, 2007; 7:1278-87. Impact Factor 6.423. Times Cited: 27 (from Web of Science). S.A. Van Grieken, L.J. Dupont, D.E. Van Raemdonck, P. Van Bleyenbergh, G.M. Verleden. Primary cryptococcal cellulitis in a lung transplant recipient. Journal of Heart and Lung Transplantation, 2007; 26:285-9. Impact Factor 3.087. Times Cited: 10 (from Web of Science). B.M. Vanaudenaerde, W.A. Wuyts, N. Geudens, L.J. Dupont, K. Schoofs, S. Smeets, D.E. Van Raemdonck, G.M. Verleden. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. American Journal of Transplantation, 2007; 7:76-82. Impact Factor 6.423. Times Cited: 64 (from Web of Science). 2006 L.J. Dupont, Y. Dewandeleer, B. Vanaudenaerde, D.E. Van Raemdonck, G.M. Verleden. The pH is reduced in exhaled breath condensate of patients with chronic rejection after (heart)lung transplantation American Journal of Transplantation, 2006; 6:1486-1492. Impact Factor 6.423. Times Cited: 18 (from Web of Science). G.M. Verleden, B. Vanaudenaerde, L.J. Dupont. Azithromycin reduces airway neutrophilia and IL-8 in patients with bronchiolitis obliterans syndrome. American Journal of Respiratory and Critical Care Medicine, 2006; 174:566-570. Impact Factor 9.074. Times Cited: 123 (from Web of Science). D.M. Bullens, E. Truyen, L. Coteur, E. Dilissen, P.W. Hellings, L.J. Dupont, J.L. Ceuppens. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respiratory Research, 2006; 7:135. Impact Factor 3.622. Times Cited: 190 (from Web of Science). M. Proesmans, W. Balinska-Miskiewicz, L. Dupont, X. Bossuyt, J. Verhaegen, N. Hoiby, K. De Boeck. Evaluation of Lee’s criteria for Pseudomonas infection in a cystic fibrosis centre European Respiratory Journal, 2006; 27:937-43. Impact Factor 5.349. Times Cited: 27 (from Web of Science). E. Truyen, L. Coteur, E. Dilissen, L. Overbergh, L.J. Dupont, J.L. Ceuppens, D.M. Bullens.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 13 / 16
Curriculum vitae
Lieven Dupont
Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax, 2006; 61:202-8. Impact Factor 6.226. Times Cited: 76 (from Web of Science). B.M. Vanaudenaerde, L.J. Dupont, W.A. Wuyts, E.K. Verbeken, I. Meyts, D.M. Bullens, E. Dilissen, L. Luyts, D.E.Van Raemdonck, G.M. Verleden. The role of interleukin-17 during acute rejection after lung transplantation. European Respiratory Journal, 2006; 27:779-87. Impact Factor 5.349. Times Cited: 100 (from Web of Science). G.M. Verleden, L.J. Dupont. Inhaled cyclosporine in lung transplantation (Letter). New England Journal of Medicine, 2006; 354:141-50. Impact Factor 51.296. Times Cited: 3 (from Web of Science). E. Van Hoeyveld, L. Dupont, X. Bossuyt. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clinical Chemistry, 2006; 52:1785-93. Impact Factor 4.803. Times Cited: 17 (from Web of Science). W. Janssens, D. Van Raemdonck, L. Dupont, G.M. Verleden. Listeria pleuritis 1 week after lung transplantation. Journal of Heart and Lung Transplantation, 2006; 25:734-7. Impact Factor 3.087. Times Cited: 7 (from Web of Science). 2005 D. Sifrim, L. Dupont, K. Blondeau, X. Zhang, J. Tack, J. Janssens. Weakly acidic reflux in patients with chronic unexplained cough during 24-hour ambulatory manometric-impedance pHmetry Gut, 2005; 54:449-454. Impact Factor 10.734. Times Cited: 161 (from Web of Science). G.M. Verleden, L..J. Dupont, D. Van Raemdonck. Is it BOS or is it chronic rejection: a reappraisal.' European Respiratory Journal, 2005; 25:221-224. Impact Factor 5.349. Times Cited: 33 (from Web of Science). G.M. Verleden, L.J. Dupont, J. Vanhaecke, W. Daenen, D.E. Van Raemdonck. Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe allograft dysfunction: a case report. Journal of Heart and Lung Transplantation, 2005; 24:1155-1158. Impact Factor 3.087. Times Cited: 19 (from Web of Science). L.J. Dupont, E. Potvin, D. Korn, A. Lachman, M. Dramaix, J. Gusman, R. Peché. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. Current medical research and opinion, 2005; 21:863-869. Impact Factor 2.962. Times Cited: 13 (from Web of Science). W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, D.E. Van Raemdonck, M.G. Demedts, G. M. Verleden. IL-17-induced IL-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kB. Journal of Heart and Lung Transplantation, 2005; 24:875-881. Impact Factor 3.087. Times Cited: 33 (from Web of Science). F. Dobbels, J. Vanhaecke, A. Desmyttere, L Dupont, F. Nevens, S. De Geest. Prevalence and correlates of self-reported nonadherence to medication in heart, liver and lung transplant candidates. American Journal of transplantation, 2005; 79:1588-1595. Impact Factor 6.423. Times Cited: 28 (from Web of Science). W.A. Wuyts, H. Molzahn, J. Maertens, E.K. Verbeken, K. Lagrou, L.J. Dupont, G.M. Verleden. Fatal Scopulariopsis infection in a lung transplant recipient: a case report.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 14 / 16
Curriculum vitae
Lieven Dupont
Journal of Heart and Lung Transplantation, 2005; 24:2301-4. Impact Factor 3.087. Times Cited: 12 (from Web of Science). 2004 W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, D.E. Van Raemdonck, M.G. Demedts, G. M. Verleden. N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung rejection? Journal of Heart and Lung Transplantation, 2004; 23:122-127. Impact Factor 3.087. Times Cited: 13 (from Web of Science). P.G.A. Van Hoydonck, W.A. Wuyts, B.M. Vanaudenaerde, E.G. Schouten, L.J. Dupont, E.H.M. Temme. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. European Respiratory Journal, 2004; 23:189-192. Impact Factor 5.349. Times Cited: 47 (from Web of Science). G.M. Verleden, L.J. Dupont. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation Transplantation, 2004; 77:1465-1467. Impact Factor 3.641. Times Cited: 89 (from Web of Science). G.M. Verleden, L.J. Dupont, D.E. Van Raemdonck, J. Vanhaecke. Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation. Transplantation, 2004; 78:730-733. Impact Factor 3.641. Times Cited: 16 (from Web of Science). 2003 L.J. Dupont, M.G. Demedts, G.M. Verleden. Prospective evaluation of the validity of exhaled NO for the diagnosis of asthma Chest, 2003; 123:751-756. Impact Factor 4.143. Times Cited: 133 (from Web of Science). G.M. Verleden, L.J. Dupont, M. Delcroix, D. Van Raemdonck, J.Vanhaecke, T. Lerut, M. Demedts. ‘Exhaled nitric oxide after lung transplantation: impact of the native lung.’ European Respiratory Journal, 2003; 21:429-432. Impact Factor 5.349. Times Cited: 11 (from Web of Science). W.A. Wuyts, B.M. Vanaudenaerde, J.L. Pype, L.J. Dupont, M.G. Demedts, G.M. Verleden. ‘Involvement of p38 MAPkinase, JNK and NF-B in interleukin 1ß-induced chemokine release: modulation by cAMP.’ Respiratory Medicine, 2003; 97:811-817. Impact Factor 2.235. Times Cited: 48 (from Web of Science). W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, M.G. Demedts, G. M. Verleden. N-Acetylcysteine reduces chemokine release via inhibition of p38 MAPK activation in human airway smooth muscle cells. European Respiratory Journal, 2003; 22:43-49. Impact Factor 5.349. Times Cited: 21 (from Web of Science). W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, M.G. Demedts, G. M. Verleden. Modulation by camp of IL-1-induced eotaxin and MCP-1 expression and release in Human Airway Smooth Muscle cells. European Respiratory Journal, 2003; 22: 220-226. Impact Factor 5.349. Times Cited: 29 (from Web of Science). G.M. Verleden, L.J. Dupont, D. Van Raemdonck, J. Vanhaecke. Effect of switching from cyclosporine to tacrolimus on exhaled NO and pulmonary function in patients with chronic rejection after lung transplantation. Journal of Heart and Lung Transplantation, 2003; 22:908-913. Impact Factor 3.087. Times Cited: 25 (from Web of Science). B.M. Vanaudenaerde, W.A. Wuyts, L.J. Dupont, D.E. Van Raemdonck, M.G. Demedts, G. M. Verleden.
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 15 / 16
Curriculum vitae
Lieven Dupont
Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. Journal of Heart and Lung Transplantation, 2003; 22:1280-1283. Impact Factor 3.087. Times Cited: 48 (from Web of Science). Projects
Memberships
several reesearch projects in cystic fibrosis, chronic rejection after lung transplantation and chronic cough
member of the BVP (Belgische Vereniging voor Pneumologie), the VSK (Vereniging voor Sport- en Keuringsartsen), the ERS (European Respiratory Society), the ATS (American Thoracic Society, the ECFS (European Cystic Fibrosis Society), the EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration)
Other Relevant Information
1/12/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 16 / 16
